Get the Stockscreener App
12.41
1.27%
-0.16
After Hours:
12.41
Alvotech Stock (ALVO) Latest News
Alvotech Breaks Below 200-Day Moving AverageNotable for ALVO - Nasdaq
FDA accepts Teva, Alvotech BLAs for Simponi biosimilars - MSN
Alvotech (NASDAQ:ALVO) Sees Significant Growth in Short Interest - MarketBeat
Alvotech And Teva Claim First US Golimumab Filing - News & Insights
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket - Benzinga
Alvotech and Teva Announce Filing Acceptance of U.S. - GlobeNewswire
FDA accepts Teva, Alvotech BLAs for Simponi biosimilars (TEVA:NYSE) - Seeking Alpha
FDA Accepts Alvotech’s Biosimilar to Simponi (Golimumab) for Review - Contract Pharma
FDA Accepts Alvotech’s Biosimilar Applications for Review - TipRanks
Alvotech and Teva Pharmaceuticals Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, A Proposed Biosimilar to Simponi® and Simponi Aria® - Marketscreener.com
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab) - GlobeNewswire Inc.
Alvotech's (NASDAQ:ALVO) largest shareholders are private equity firms with 34% ownership, private companies own 31% - Yahoo Finance
Private equity firms account for 34% of Alvotech's (NASDAQ:ALVO) ownership, while private companies account for 31% - Simply Wall St
J&J stands by sales growth ambitions—and points to potential Tremfya boon—as Stelara biosimilars take hold - FiercePharma
JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Benzinga
Has Alvotech (ALVO) Outpaced Other Medical Stocks This Year? - MSN
Alvotech : Transactions of Managers and Closely Associated Persons - Marketscreener.com
Alvotech : Managers' transactionsALVOTECH -January 15, 2025 at 04:03 pm EST - Marketscreener.com
Alvotech (NASDAQ:ALVO) Sees Large Growth in Short Interest - MarketBeat
Alvotech (NASDAQ:ALVO) Shares Gap UpWhat's Next? - MarketBeat
Alvotech birtir fjárhagsdagatal fyrir árið 2025 - GlobeNewswire
Alvotech Eyes Growth As Product Revenue Soars And New Launches ApproachWill The Stock Follow? - RTTNews
Are Medical Stocks Lagging Alvotech (ALVO) This Year? - Yahoo Finance
Alvotech (NASDAQ:ALVO) Short Interest Update - MarketBeat
Alvotech Joins Nasdaq Biotechnology Index, Boosting Industry Presence - TipRanks
Alvotech : Added to Nasdaq Biotech Index Effective Monday December 23, 2024 Form 6 K - Marketscreener.com
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024 - The Manila Times
Alvotech Secures Coveted Spot in Nasdaq Biotechnology Index Following Strong Market Performance - StockTitan
ALVOAlvotech Ordinary Shares Latest Stock News & Market Updates - StockTitan
Wall Street Analysts Believe Alvotech (ALVO) Could Rally 39.83%: Here's is How to Trade - MSN
Alvotech's SWOT analysis: biosimilar powerhouse stock faces b2b model challenges - Investing.com
Is Alvotech (ALVO) Stock Outpacing Its Medical Peers This Year? - MSN
Eye on Pharma: Golimumab Biosimilar Update; Korea Approves Denosumab; Xbrane, Intas Collaboration - The Center for Biosimilars
Alvotech (NASDAQ:ALVO) Is Expected To Breakeven In The Near Future - Simply Wall St
Short Interest in Alvotech (NASDAQ:ALVO) Rises By 47.8% - MarketBeat
Alvotech’s Eylea Biosimilar ‘Keeps In Mind’ US Patent Landscape - Citeline
Alvotech's SWOT analysis: biosimilars powerhouse stock faces growth hurdles - Investing.com
Alvotech (ALVO) Shares Gap Down to $11.94 on Nov 22 - GuruFocus.com
Are Medical Stocks Lagging CareCloud (CCLD) This Year? - Yahoo Finance
Alvotech’s Position In The Coming Biosimilar Gold Rush (NASDAQ:ALVO) - Seeking Alpha
Alvotech (ALVO) Q3 Earnings and Revenues Beat Estimates - MSN
Alvotech Third Quarter 2024 Earnings: US$0.041 loss per share (vs US$0.81 loss in 3Q 2023) - Yahoo Finance
Earnings call: Alvotech reported revenues of $128 million - Investing.com India
Alvotech (ALVO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements - Investing.com Canada
Alvotech Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call: Alvotech reported revenues of $128 million By Investing.com - Investing.com Canada
Alvotech earnings missed, revenue fell short of estimates By Investing.com - Investing.com Nigeria
1.11%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):